A Auranen

Summary

Affiliation: University of Turku
Country: Finland

Publications

  1. ncbi request reprint Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature
    A Auranen
    Departments of Obstetrics and Gynecology and Pathology, Turku University Hospital, Turku, Finland
    Int J Gynecol Cancer 17:1011-8. 2007
  2. doi request reprint A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families
    Annika Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Finland
    Acta Obstet Gynecol Scand 90:437-44. 2011
  3. pmc Cancer incidence in the first-degree relatives of ovarian cancer patients
    A Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Finland
    Br J Cancer 74:280-4. 1996
  4. pmc Segregation analysis of epithelial ovarian cancer in Finland
    A Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Finland
    Br J Cancer 77:1537-41. 1998
  5. pmc Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
    K Huhtinen
    Department of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland
    Br J Cancer 100:1315-9. 2009
  6. ncbi request reprint BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families
    L Sarantaus
    Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Haartmaninkatu 2, FIN-00029 HUCH, Finland
    Int J Oncol 18:831-5. 2001
  7. doi request reprint Radiation therapy and biological compounds for consolidation therapy in advanced ovarian cancer
    A Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland
    Int J Gynecol Cancer 18:44-6. 2008
  8. ncbi request reprint Hormonal treatments and epithelial ovarian cancer risk
    A Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland
    Int J Gynecol Cancer 15:692-700. 2005

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature
    A Auranen
    Departments of Obstetrics and Gynecology and Pathology, Turku University Hospital, Turku, Finland
    Int J Gynecol Cancer 17:1011-8. 2007
    ..FIGO stage and tumor rupture were the only factors associated with the outcome of GCT. Treatment of relapse, even in case of multiple recurrences, is usually worthwhile...
  2. doi request reprint A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families
    Annika Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Finland
    Acta Obstet Gynecol Scand 90:437-44. 2011
    ....
  3. pmc Cancer incidence in the first-degree relatives of ovarian cancer patients
    A Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Finland
    Br J Cancer 74:280-4. 1996
    ..Among the 27 families with two or more ovarian cancers, only sisters were affected in 24 families, which might implicate recessive inheritance or shared environmental factors influencing ovarian cancer risk in sisters...
  4. pmc Segregation analysis of epithelial ovarian cancer in Finland
    A Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Finland
    Br J Cancer 77:1537-41. 1998
    ..Results of this analysis, however, strongly emphasize the role of genetic factors in all familial aggregation of epithelial ovarian cancer...
  5. pmc Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
    K Huhtinen
    Department of Physiology, Institute of Biomedicine, University of Turku, Turku, Finland
    Br J Cancer 100:1315-9. 2009
    ..Taken together, measuring both HE4 and CA125 serum concentrations increases the accuracy of ovarian cancer diagnosis and provides valuable information to discriminate ovarian tumours from ovarian endometriotic cysts...
  6. ncbi request reprint BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families
    L Sarantaus
    Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Haartmaninkatu 2, FIN-00029 HUCH, Finland
    Int J Oncol 18:831-5. 2001
    ..e. two affected cases) remained mutation-negative...
  7. doi request reprint Radiation therapy and biological compounds for consolidation therapy in advanced ovarian cancer
    A Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland
    Int J Gynecol Cancer 18:44-6. 2008
    ..Evaluation of new agents is indicated in order to achieve long-term disease-free survival in these patients. Toxicity and ease of administration must be reflected against the benefits of therapy...
  8. ncbi request reprint Hormonal treatments and epithelial ovarian cancer risk
    A Auranen
    Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland
    Int J Gynecol Cancer 15:692-700. 2005
    ..This review discusses the risk of ovarian cancer associated with the use of sex steroid hormones, with special emphasis on the possible risk associated with estrogens...